16 devices · GMDN 63752
This category includes immunoglobulins designed to bind specifically to glypican-3, a protein often overexpressed in certain liver cancers and other malignancies. These antibodies are used in laboratory tests to detect the presence and amount of glypican-3 in patient samples such as tissue or blood, aiding in diagnosis, prognosis, or monitoring of disease.
Devices in this category are in vitro diagnostic (IVD) reagents intended for use with analytical instruments or assays to measure glypican-3 levels. They are supplied as standalone antibody components or as part of test kits and are regulated based on their intended use for clinical specimen analysis, without including any therapeutic or medicinal components.
This category summary is AI-generated from the GMDN nomenclature and has not been verified by a human reviewer.